10-K/A: QuidelOrtho Amends 2023 Annual Report to Include Additional Audit Details

QuidelOrtho Corporation files an amendment to its 2023 annual report to include additional details under Critical Audit Matters, while reaffirming its unqualified opinion on the financial statements.

Summary

• QuidelOrtho Corporation has filed an amendment to its original 2023 annual report on Form 10-K, solely to add paragraphs under the heading Critical Audit Matters to the Report of Independent Registered Public Accounting Firm.
• The amendment does not change any other information in the original report, including the financial statements, which remain unchanged.
• The corrected report continues to express an unqualified opinion on the company's consolidated financial statements for the years ended December 31, 2023, and January 1, 2023.
• The company has included updated certifications from the Principal Executive Officer and Principal Financial Officer as required by the Sarbanes-Oxley Act of 2002.
• The original report was filed on February 29, 2024, and this amendment speaks as of that date.

Sentiment

Score: 4

Explanation: The document is primarily factual and reports a net loss, which is a negative indicator. The amendment itself is neutral, but the overall financial results and the need for additional audit details suggest some underlying issues.

Positives

• The independent auditor continues to express an unqualified opinion on the company's financial statements.
• The company has taken steps to address critical audit matters by providing additional details.
• The company's total stockholders equity was $5,005.9 million as of December 31, 2023.

Negatives

• The company reported a net loss of $10.1 million for 2023.
• The company's cash and cash equivalents decreased from $292.9 million to $118.9 million year over year.
• The company's accounts receivable decreased from $453.9 million to $303.3 million year over year.

Risks

• The company's allowance for contractual rebates is subject to estimation uncertainty due to the high volume of data and varying customer terms.
• The company's goodwill impairment assessment involves significant judgment due to the estimation uncertainty in determining the fair value of reporting units.
• The company's use of its net operating loss and tax credit carryforwards may be limited due to ownership changes.
• The company is subject to periodic audits by domestic and foreign tax authorities, which could result in adjustments to its tax liabilities.

Future Outlook

The document does not contain any specific forward-looking statements or guidance, as it is an amendment to a previously filed annual report.

Management Comments

• The Principal Executive Officer and Principal Financial Officer have certified that the report does not contain any untrue statement of a material fact and fairly presents the company's financial condition, results of operations, and cash flows.

Industry Context

This amendment is a standard regulatory filing and does not indicate any specific industry trends or competitive pressures. The additional details in the Critical Audit Matters section are specific to QuidelOrtho's financial reporting and audit process.

Comparison to Industry Standards

• The company's financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP), which is the standard for financial reporting in the United States.
• The audit was conducted in accordance with the standards of the Public Company Accounting Oversight Board (PCAOB), which is the standard for auditing public companies in the United States.
• The company's financial metrics, such as revenue, net loss, and goodwill, are comparable to other companies in the diagnostics and medical device industry, but specific comparisons would require a more detailed analysis of peer companies such as Abbott Laboratories, Danaher Corporation, and Thermo Fisher Scientific.
• The critical audit matters related to contractual rebates and goodwill impairment are common areas of focus for auditors in the healthcare industry, where complex revenue recognition and valuation issues are prevalent.

Stakeholder Impact

• Shareholders may be concerned about the reported net loss and the need for additional audit details.
• Employees may be affected by any potential changes in the company's financial performance.
• Customers and suppliers may be impacted by any changes in the company's operations or financial stability.
• Creditors may be concerned about the company's ability to repay its debts.

Next Steps

• The company will continue to operate under the guidance of its existing management and board.
• The company will continue to monitor and address any issues identified in the audit process.
• The company will continue to comply with all applicable regulations and reporting requirements.

Key Dates

Keywords

financial statements, audit, goodwill, rebates, revenue, net loss, internal control, Sarbanes-Oxley Act, critical audit matters, financial reporting